Scholar Rock Holding Corporation (NASDAQ:SRRK) Receives Consensus Rating of "Buy" from Brokerages

Key Points

• Scholar Rock has a consensus “Buy” rating from 17 analysts: 12 rate it Buy, four Strong Buy, and one Sell. The average 12-month price target is $57.71.
• Recent analyst actions were broadly positive, including upgraded price targets from Citigroup to $60 and BMO Capital Markets’ $76 target, while Barclays and Wedbush maintained bullish ratings.
• SRRK shares opened at $56.51, near their 52-week high of $58.49, and the company reported quarterly EPS of negative $0.84, in line with analyst expectations. Institutional investors own 91.08% of the stock.

Scholar Rock Holding Corporation (NASDAQ:SRRK - Get Free Report) has received an average recommendation of "Buy" from the seventeen analysts that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, twelve have assigned a buy rating and four have given a strong buy rating to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $57.7143.

SRRK has been the subject of a number of analyst reports. Weiss Ratings restated a "sell (d-)" rating on shares of Scholar Rock in a report on Friday, July 17th. Citigroup lifted their price target on shares of Scholar Rock from $58.00 to $60.00 and gave the stock a "buy" rating in a research report on Friday, August 7th. BMO Capital Markets reissued an "outperform" rating and issued a $76.00 price target on shares of Scholar Rock in a report on Friday, August 7th. Barclays boosted their price target on shares of Scholar Rock from $53.00 to $55.00 and gave the company an "overweight" rating in a report on Friday, May 8th. Finally, Wedbush restated an "outperform" rating and issued a $58.00 price objective on shares of Scholar Rock in a research report on Monday, August 10th.

Insider Transactions at Scholar Rock

In other Scholar Rock news, Director Katie Peng sold 5,446 shares of the business's stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $53.88, for a total value of $293,430.48. Following the completion of the transaction, the director directly owned 34,301 shares of the company's stock, valued at approximately $1,848,137.88. The trade was a 13.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Jeffrey S. Flier sold 3,053 shares of the stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $53.88, for a total value of $164,495.64. Following the completion of the sale, the director owned 27,856 shares of the company's stock, valued at $1,500,881.28. This trade represents a 9.88% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders sold 17,149 shares of company stock valued at $923,108. Insiders own 10.30% of the company's stock.

Institutional Trading of Scholar Rock

A number of large investors have recently bought and sold shares of the business. IFP Advisors Inc raised its holdings in Scholar Rock by 294.1% during the 4th quarter. IFP Advisors Inc now owns 603 shares of the company's stock worth $27,000 after buying an additional 450 shares during the period. Allworth Financial LP acquired a new position in shares of Scholar Rock in the second quarter valued at approximately $35,000. Caitong International Asset Management Co. Ltd acquired a new position in shares of Scholar Rock in the fourth quarter valued at approximately $30,000. Summit Securities Group LLC bought a new stake in shares of Scholar Rock during the fourth quarter worth $31,000. Finally, EverSource Wealth Advisors LLC increased its position in shares of Scholar Rock by 151.3% during the fourth quarter. EverSource Wealth Advisors LLC now owns 872 shares of the company's stock worth $38,000 after acquiring an additional 525 shares in the last quarter. 91.08% of the stock is owned by institutional investors.

Scholar Rock Price Performance

Shares of SRRK opened at $56.51 on Thursday. The stock has a market cap of $6.88 billion, a P/E ratio of -16.38 and a beta of 0.69. Scholar Rock has a 1 year low of $27.07 and a 1 year high of $58.49. The stock's 50-day moving average price is $51.40 and its two-hundred day moving average price is $48.34. The company has a current ratio of 7.02, a quick ratio of 7.02 and a debt-to-equity ratio of 0.77.

Scholar Rock (NASDAQ:SRRK - Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported ($0.84) EPS for the quarter, meeting analysts' consensus estimates of ($0.84). During the same period in the prior year, the firm earned ($0.98) earnings per share. On average, equities analysts predict that Scholar Rock will post -3.23 earnings per share for the current year.

About Scholar Rock

Scholar Rock is a clinical-stage biotechnology company focused on the discovery and development of protein therapeutics that selectively target growth factors involved in disease processes. The company's research platform is designed to modulate endogenous growth factor activation and signaling with high specificity, aiming to restore normal biological function across a range of disorders. Scholar Rock's approach is distinguished by its emphasis on engineering antibodies and biologics that interact with growth factor precursors or latent complexes rather than the active form, potentially offering improved safety and efficacy profiles.

The company's lead program, SRK-015 (appercept), is an investigational monoclonal antibody targeting the activation of latent myostatin proproteins and is being evaluated for the treatment of spinal muscular atrophy (SMA).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source